Risk analysis of non-melanoma skin cancer incidence in arsenic exposed population

Arsenic Exposure and Health Effects V

Volumn , Issue , 2003, Pages 147-154

  Bencko, Vladimír ^a   Rameš, Jiří ^b   Götzl, Miloslav ^c   Franěk, Petr ^d   Jakubis, Marián ^e  

^a CHARLES UNIVERSITY   (Czech Republic)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c Department of Oncology District Hospital of Bojnice ^*  (Slovakia)

^d INSTITUTE OF MATHEMATICS   (Czech Republic)

^e State Institute of Health Prievidza   (Slovakia)

Author keywords

Arsenic toxicity; Biological monitoring; cancer epidemiology; Non melanoma skin cancer

Indexed keywords

ARSENIC; COAL; DISEASES; FOSSIL FUEL POWER PLANTS; ONCOLOGY; POPULATION STATISTICS; RISK ANALYSIS; RISK ASSESSMENT;

ARSENIC EXPOSURE; ARSENIC TOXICITY; BIOLOGICAL MONITORING; CANCER EPIDEMIOLOGIES; EXPOSURE ASSESSMENT; HISTOLOGICAL EXAMINATION; POSITIVE CORRELATIONS; SKIN CANCERS;

DERMATOLOGY;

EID: 58149287177     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044451441-7/50012-9     Document Type: Chapter

References (19)

1. ATSDR Toxicological profile for arsenic 1998, 341. US Department of Health and Human Services.
2. Bencko V. Use of human hair as a biomarker in the assessment of exposure to pollutants in occupational and environmental settings. Toxicology 1995, 101:29-39.
3. Bencko V. Health aspects of burning coal with a high arsenic content: the Central Slovakia experience. Arsenic, Exposure and Health Effects 1997, 84-92. Chapman & Hall, New York. C.O. Abernathy, R.L. Calderon, W.R. Chappell (Eds.).
4. Bencko V., Symon K., Štálnik L., Bątora J., Vančo E., Šrandov E. Rate of malignant tumor mortality among coal burning power plant workers occupationally exposed to arsenic. J. Hyg. Epidemiol. (Praha) 1980, 24(3):278-284.
5. Q3 Bencko V., Rameš J., Götzl M. Preliminary incidence analysis in skin basalioma patients exposed to arsenic in environmental and occupational settings. Arsenic Exposure and Health Effects 1999, 201-206. Elsevier. C.O. Abernathy, R.L. Calderon, W.R. Chappell (Eds.).
6. Buchancová J., Klimentová G., Kniková M., Meško D., Gáliková E., Kubík J., Fabiánová E., Jakubis M. A health status of workers of a thermal power station exposed for prolonged periods to arsenic and other elements from fuel. Cent. Eur. J. Public Health 1998, 6:29-36.
7. Chuang T.Y., Brashear R. Risk factors of non-melanoma skin cancer in United States veterans patients: a pilot study and review of literature. J. Eur. Acad. Dermatol. Venereol. 1999, 12:126-132.
8. Fabiánová E., Bencko V. Central European study on health impact of environmental pollution. Final report, project PHARE EC/91/HEA/18 1995, European Union, Brussels, Belgium.
9. Fabiánová E., Hettychová L'., Hrubá F. Occupational exposure assessment and bioavailability of arsenic. Final report. EPRI Research Agreement RP 3370-12 1994, 106.
10. Karagas M.R., Stukel T.A., Morris J.S., Tosteson T.D., Weiss J.E., Spencer S.K., Greenberg E.R. Skin cancer risk in relation to tocnail arsenic concentrations in a US population-based case-control study. Am. J. Epidemiol. 2001, 153(6):559-565.
11. Lear J.T., Tan B.B., Smith A.G., Jones P.W., Heagerty A.H., Strange R.C., Fryer A.A. A comparison of risk factors for malignant melanoma, squamous cell carcinoma and basal cell carcinoma in the UK. Int. J. Clin. Pract. 1998, 52:145-149.
12. Nieuwenhuijsen M.J., Rautiu R., Ranft U., Bencko V., Cordos E. Exposure to arsenic and cancer risk in central and east Europe. Final report, project EXPASCAN IC 15 CT98 0325 2001, March 31, European Union, Brussels, Belgium.
13. Niu S., Cao S., Shen E. The geochemistry of arsenic. Arsenic, Exposure and Health Effects 1997, 78-83. Chapman & Hall, New York. C.O. Abernathy, R.L. Calderon, W.R. Chappell (Eds.).
14. Pesch B., Ranft U., Jakubis P., Nieuwenhuijsen M.J., Hergemoller A., Unfried K., Jakubis M., Miskovic P., Keegan T. Environmental arsenic exposure from a coal-burning power plant as a potential risk factor for non-melanoma skin carcinoma: results from a case-control study in the district of Prievidza. Slovakia. Am. J. Epidemiol. 2002, 155(9):798-809.
15. Pleško I., Severi G., Obšitníková A., Boyle P. Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-95. Neoplasma 2000, 47(3):137-142.
16. Q3 Rossman T.G. Arsenic genotoxicity may be mediated by interference with DNA damage-inducible signaling. Arsenic Exposure and Health Effects 1999, 233-241. Elsevier. C.O. Abernathy, R.L. Calderon, W.R. Chappell (Eds.).
17. Seidl H., Kreimer-Erlacher H., Back B., Soyer H.P., Hofler G., Kerl H., Wolf P. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis. J. Invest. Dermatol. 2001, 117(2):365-370.
18. Thornton I., Farago M. The geochemistry of arsenic. Arsenic, Exposure and Health Effects 1997, 1-16. Chapman & Hall, New York. C.O. Abernathy, R.L. Calderon, W.R. Chappell (Eds.).
19. van Dam R.M., Huang Z., Rimm E.B. Risk factors for basal cell carcinoma of the skin in men: results from the Health Professionals Follow-up Study. Am. J. Epidemiol. 1999, 150:459-468.